Want to see CLVT full AI Analyst Report?
CLVT Stock Chart & Stats
$2.68
-$0.17(-3.38%)
At close: 4:00 PM EST
$2.68
-$0.17(-3.38%)
Day’s Range― - ―
52-Week Range$1.66 - $4.77
Previous CloseN/A
Volume814.08K
Average Volume (3M)4.90M
Market Cap
$1.53B
Enterprise Value$5.71K
Total Cash (Recent Filing)$232.30M
Total Debt (Recent Filing)$4.33B
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Jul 29, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding639,216,500
10 Day Avg. Volume4,496,965
30 Day Avg. Volume4,903,935
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.46
Price to Sales (P/S)0.92
P/FCF Ratio6.16
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.38Price Target Upside26.12% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)0.74
Revenue Forecast (FY)$2.34B
Bulls Say, Bears Say
Bulls Say
High And Expanding MarginsSustained high gross margins and improving adjusted EBITDA margins reflect a scalable, software-driven subscription model with strong pricing power and operating leverage. Higher margins provide durable capacity to invest in product development, AI initiatives, and margin-accretive growth while absorbing revenue volatility.
Strong Free Cash Flow GenerationMaterial positive free cash flow despite GAAP losses indicates robust cash conversion from subscription businesses. Reliable FCF supports debt reduction, targeted buybacks or M&A, and continued product investment, enabling deleveraging and greater financial optionality over the coming months.
Portfolio Simplification And Debt Reduction PlanSelling LS&H is a structural refocus to a subscription-first IP and academia business, reducing capital intensity and improving recurring revenue mix. The proceeds earmarked for debt repayment accelerate deleveraging, lower interest expense and can materially improve leverage ratios and margin sustainability.
Bears Say
Sharp Revenue ContractionSignificant trailing revenue declines indicate demand or portfolio effects that impair scale economies. Even with margin improvement, shrinking top line compresses long-term growth optionality, raises reliance on cost cuts and disposals, and makes sustaining R&D and sales investments more challenging.
Ongoing GAAP Net LossesPersistent GAAP losses and negative ROE highlight that accounting profitability has not been restored despite operational progress. This reduces retained-earnings capacity to self-fund growth, keeps equity returns weak, and sustains investor and creditor scrutiny around long-term viability until consistent GAAP profits emerge.
Material Cash Tax And Portfolio-decision RisksA substantially higher cash tax bill would materially reduce projected free cash flow and slow planned deleveraging. Coupled with guidance that depends on portfolio disposals, this tax and transaction uncertainty can constrain capital allocation, raise refinancing pressure, and impair multi-quarter financial planning.
Clarivate News
CLVT FAQ
What was Clarivate Plc’s price range in the past 12 months?
Clarivate Plc lowest stock price was $1.66 and its highest was $4.77 in the past 12 months.
What is Clarivate Plc’s market cap?
Clarivate Plc’s market cap is $1.53B.
When is Clarivate Plc’s upcoming earnings report date?
Clarivate Plc’s upcoming earnings report date is Jul 29, 2026 which is in 7 days.
How were Clarivate Plc’s earnings last quarter?
Clarivate Plc released its earnings results on Apr 29, 2026. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.145 by $0.035.
Is Clarivate Plc overvalued?
According to Wall Street analysts Clarivate Plc’s price is currently Undervalued.
Does Clarivate Plc pay dividends?
Clarivate Plc does not currently pay dividends.
What is Clarivate Plc’s EPS estimate?
Clarivate Plc’s EPS estimate is 0.18.
How many shares outstanding does Clarivate Plc have?
Clarivate Plc has 639,216,500 shares outstanding.
What happened to Clarivate Plc’s price movement after its last earnings report?
Clarivate Plc reported an EPS of $0.18 in its last earnings report, beating expectations of $0.145. Following the earnings report the stock price went up 13.944%.
Which hedge fund is a major shareholder of Clarivate Plc?
Currently, no hedge funds are holding shares in CLVT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clarivate Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.38 (26.12% Upside)
$3.38 (26.12% Upside)
Blogger Sentiment
Bullish
CLVT Sentiment 100%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Decreased
By 273.3K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.52%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.92%
Trailing 12-Months
Company Description
Clarivate Plc
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
CLVT Stock 12 Month Forecast
Average Price Target
$3.38
▲(26.12% Upside)
Technical Analysis
Ownership Overview
6.67% Insiders
8.61% Mutual Funds
11.07% Other Institutional Investors
65.22% Public Companies and
Individual Investors